ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P1539

   In vitro activity of cefepime alone and in combination with the broad-spectrum beta-lactamase inhibitor VNRX-5133 against ESBL and carbapenamases harbouring Enterobacteriaceae and Pseudomonas spp.

   Johan Mouton, Rotterdam, The Netherlands

   R. Donnelly, W. Kloezen, M. Goldman, A. Van Mil, C. Lagarde, J. Meletiadis, J. Mouton

   23 April 2018

   Session: VNRX- 5133 plus cefepime: in vitro and in vivo data

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   Abstract publication

   New Antibacterial Agents & Stewardship

2. W0014

   Carbapenem and aminoglycoside breakpoints revisited

   Johan Mouton

   21 April 2018

   Session: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

   Relevance:

    

   100%

    

   

   Event: ECCMID 2018
   Madrid, Spain
   4-Hour Educational Workshop

   Bacterial Susceptibility & Resistance

3. OS1020

   Population pharmacokinetics of Murepavadin (POL7080) and Monte Carlo simulations to develop clinical dosing regimens, including the renally impaired

   Johan Mouton, Rotterdam, The Netherlands

   Brenda De Winter, Anouk Muller, Glenn Dale, Achim Wach, Johan Mouton

   25 April 2017

   Session: PK/PD: what you need to learn for new and old-revived antibiotics

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   New Antibacterial Agents & Stewardship

4. EP0943

   Population pharmacokinetics, Monte Carlo simulations and dosing recommendations of cefepime using 2h infusion, including renal impairment

   Johan Mouton, Rotterdam, The Netherlands

   Anouk Muller, Sachin Bhagwat, Mahesh Patel, Johan Mouton

   25 April 2017

   Session: Recent advances in PK/PD: efficacy and toxicity

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   ePoster presentation

   New Antibacterial Agents & Stewardship

5. P1299

   Population pharmacokinetics of zidebactam (WCK 5107), a novel beta-lactam enhancer antibiotic

   Johan Mouton, Rotterdam, The Netherlands

   Anouk Muller, Johan Mouton

   24 April 2017

   Session: Zidebactam and other new Gram-negative antibiotic potentiators

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Abstract publication

   New Antibacterial Agents & Stewardship

6. P1179

   Population pharmacokinetics, Monte Carlo simulations and dose adjustment of tazobactam including in the renally impaired

   Johan Mouton, Rotterdam, The Netherlands

   Anouk Muller, Mahesh Patel, Sachin Bhagwat, Johan Mouton

   24 April 2017

   Session: PK/PD studies in humans

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Abstract publication

   New Antibacterial Agents & Stewardship

7. Current tools and approaches for setting breakpoints

   Johan Mouton, Rotterdam, The Netherlands

   21 September 2016

   Relevance:

    

   100%

    

   

   Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
   Vienna, Austria
   Conference lecture

   Bacterial Susceptibility & Resistance

8. Setting breakpoints for EUCAST

   Johan Mouton, Rotterdam, The Netherlands

   20 September 2016

   Relevance:

    

   100%

    

   

   Event: Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic. A EUCAST, ESGARS and EPASG Perspective
   Bochum, Germany
   PGTW lecture

   Bacterial Susceptibility & Resistance

9. New approaches to circumvent Staphylococcus multiresistance

   Johan Mouton, Rotterdam, The Netherlands

   01 July 2016

   Relevance:

    

   100%

    

   

   Event: Virulence and Resistance in Staphylococcus aureus: 2016 State of the Art
   Lyon, France
   PGEC lecture

   Bacterial Susceptibility & Resistance

10. P1179

    Biochemical and structural characterization of OXA-405, an OXA-48 variant with extended-spectrum beta-lactamase activity

    Saoussen Oueslati, Le Kremlin-Bicetre, France

    S. Oueslati, P. Retailleau, L. Dortet, B. Iorga, T. Naas

    11 April 2016

    Session: Deciphering carbapenem resistance

    Relevance:

     

    100%

     

    

    Event: ECCMID 2016
    Amsterdam, The Netherlands
    Poster presentation

    Bacterial Susceptibility & Resistance